Profile data is unavailable for this security.
About the company
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
- Revenue in HKD (TTM)4.58bn
- Net income in HKD658.92m
- Incorporated2004
- Employees5.70k
- LocationSSY Group LtdRooms 4902-03, 49th Floor, Central Plaza18 Harbour RoadWanchai Hong KongHKG
- Phone+852 26880869
- Fax+852 27873338
- Websitehttps://www.ssygroup.com.hk/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shandong Boan Biotechnology Co Ltd | 856.12m | 36.24m | 4.89bn | 714.00 | 123.65 | 1.96 | 37.12 | 5.71 | 0.0636 | 0.0636 | 1.51 | 4.00 | 0.2530 | 1.34 | 1.73 | 1,053,040.00 | 1.07 | -- | 1.41 | -- | 71.70 | -- | 4.23 | -- | 1.45 | 1.81 | 0.2827 | -- | 17.50 | -- | 161.31 | -- | -- | -- |
| VIVA Biotech Holdings | 2.08bn | 194.91m | 5.07bn | 2.09k | 33.61 | 1.14 | 10.09 | 2.44 | 0.0708 | 0.0708 | 0.6808 | 2.09 | 0.2612 | 4.24 | 4.94 | 1,007,169.00 | 3.22 | -1.28 | 3.81 | -1.56 | 37.44 | 34.30 | 12.33 | -4.94 | 1.44 | -- | 0.2283 | -- | -7.84 | 43.80 | 244.08 | -8.85 | 27.82 | -- |
| Ocumension Therapeutics | 615.09m | -281.97m | 5.65bn | 505.00 | -- | 1.36 | -- | 9.19 | -0.3764 | -0.3764 | 0.8214 | 5.08 | 0.1571 | 4.30 | 3.35 | 1,257,846.00 | -7.20 | -24.03 | -7.62 | -25.71 | 42.58 | 58.38 | -45.84 | -400.90 | 4.86 | -- | 0.0223 | -- | 69.38 | 365.95 | 29.36 | -- | 213.01 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.86bn | 488.38m | 5.69bn | 3.89k | 11.64 | 0.689 | 4.60 | 0.7235 | 0.3813 | 0.3813 | 6.14 | 6.44 | 0.482 | 0.8615 | 6.00 | 1,969,449.00 | 5.47 | 7.44 | 8.57 | 12.07 | 39.82 | 42.21 | 11.34 | 15.10 | 2.79 | -- | 0.1913 | 39.34 | 7.18 | 10.15 | -11.59 | 4.55 | -8.30 | 3.37 |
| Beijing Tong Ren Tang Chinese Medicine | 1.71bn | 515.36m | 7.54bn | 789.00 | 14.63 | 1.87 | 12.01 | 4.41 | 0.6157 | 0.6157 | 2.04 | 4.81 | 0.3878 | 0.4134 | 4.92 | 2,185,246.00 | 12.14 | 15.34 | 13.34 | 17.17 | 63.00 | 68.94 | 31.29 | 39.16 | 11.43 | -- | 0.0327 | 52.52 | 5.69 | 2.38 | -7.42 | -2.09 | 20.50 | 8.76 |
| China Shineway Pharmaceutical Group Ltd | 3.78bn | 936.95m | 8.21bn | 2.87k | 8.01 | 0.9295 | 10.54 | 2.17 | 1.24 | 1.24 | 5.01 | 10.68 | 0.3299 | 1.15 | 3.81 | 1,174,842.00 | 8.17 | 8.29 | 10.75 | 10.38 | 73.36 | 74.83 | 24.77 | 18.67 | 3.39 | -- | 0.0419 | 37.49 | -16.35 | 6.90 | -13.35 | 10.80 | 8.92 | 19.39 |
| CStone Pharmaceuticals | 229.07m | -426.59m | 8.27bn | 93.00 | -- | 21.44 | -- | 36.08 | -0.3273 | -0.3273 | 0.1768 | 0.2612 | 0.1487 | 1.38 | 1.68 | 1,696,818.00 | -27.69 | -39.13 | -54.45 | -60.19 | -12.18 | 66.69 | -186.23 | -170.86 | 1.20 | -29.83 | 0.554 | -- | -12.21 | -- | 75.16 | -- | -- | -- |
| SSY Group Ltd | 4.58bn | 658.92m | 8.81bn | 5.70k | 13.63 | 1.23 | 7.84 | 1.92 | 0.223 | 0.223 | 1.55 | 2.46 | 0.3616 | 2.27 | 2.11 | 751,065.60 | 5.27 | 9.41 | 6.34 | 12.43 | 42.68 | 56.47 | 14.58 | 17.65 | 2.40 | 14.91 | 0.346 | 42.91 | -10.67 | 4.49 | -19.53 | -1.36 | -8.36 | 9.73 |
| Hbm Holdings Ltd | 904.62m | 571.25m | 10.19bn | 210.00 | 15.82 | 4.21 | 17.04 | 11.27 | 0.7407 | 0.7407 | 1.14 | 2.78 | 0.3856 | 6.32 | 32.64 | 5,798,829.00 | 24.77 | -42.87 | 30.77 | -53.24 | 92.95 | 96.12 | 64.25 | -292.58 | 6.02 | 28.63 | 0.1857 | -- | -57.43 | 47.71 | -87.81 | -- | -55.31 | -- |
| China Traditional Chinese Med Hldg CoLtd | 17.63bn | -299.59m | 10.37bn | 15.58k | -- | 0.4429 | 11.41 | 0.5883 | -0.0595 | -0.0595 | 3.50 | 4.65 | 0.4326 | 1.59 | 1.71 | 1,052,569.00 | -0.93 | 3.48 | -1.42 | 5.24 | 47.66 | 54.69 | -2.15 | 7.39 | 1.51 | 9.55 | 0.1333 | 21.27 | -8.90 | 2.89 | -95.79 | -49.14 | -15.28 | -48.82 |
| Fujian Haixi Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.69bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.39 | -- | 15.86 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.98bn | 449.04m | 10.94bn | 5.12k | 22.95 | 0.6201 | 6.84 | 1.57 | 0.1194 | 0.1194 | 1.85 | 4.42 | 0.2083 | 2.42 | 2.37 | 1,354,872.00 | 1.91 | 1.98 | 3.26 | 3.16 | 66.85 | 68.37 | 9.15 | 8.04 | 1.24 | 2.35 | 0.4227 | 0.00 | -1.33 | -0.9503 | -11.40 | -19.50 | -10.95 | -- |
| Guangzhou Innogen Pharmaceutl Grp Co Ltd | -100.00bn | -100.00bn | 12.77bn | 105.00 | -- | 15.03 | -- | -- | -- | -- | -- | 1.84 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.39 | -- | 0.0769 | -- | -- | -- | 76.18 | -- | -- | -- |
Data as of Feb 12 2026. Currency figures normalised to SSY Group Ltd's reporting currency: Hong Kong Dollar HKD
11.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management (Europe) SAas of 19 Jan 2026 | 92.94m | 3.15% |
| UBS Switzerland AG (Investment Management)as of 19 Jan 2026 | 64.10m | 2.17% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 46.05m | 1.56% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 35.83m | 1.21% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 19.07m | 0.65% |
| UBS Asset Management (Hong Kong) Ltd.as of 19 Jan 2026 | 19.02m | 0.64% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 17.28m | 0.59% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 17.22m | 0.58% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 9.08m | 0.31% |
| American Century Investment Management, Inc.as of 08 Jan 2026 | 7.56m | 0.26% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
